Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey.

Wolf P, Weger W, Legat F, Painsi C, Saxinger W, Müllegger R, Sator P, Ratzinger G, Selhofer S, Richter L, Salmhofer W, Lange-Asschenfeldt B, Trautinger F, Mlynek A, Strohal R, Augustin M, Quehenberger F.

J Dtsch Dermatol Ges. 2018 Aug;16(8):981-990. doi: 10.1111/ddg.13613.

PMID:
30117711
2.

Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-Survey.

Wolf P, Weger W, Legat F, Painsi C, Saxinger W, Müllegger R, Sator P, Ratzinger G, Selhofer S, Richter L, Salmhofer W, Lange-Asschenfeldt B, Trautinger F, Mlynek A, Strohal R, Augustin M, Quehenberger F.

J Dtsch Dermatol Ges. 2018 Aug;16(8):981-991. doi: 10.1111/ddg.13613_g.

PMID:
30117699
3.

Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience.

Sator P.

Ther Adv Chronic Dis. 2018 Aug;9(8):147-158. doi: 10.1177/2040622318772705. Epub 2018 May 22. Review.

4.

Quantity and quality of sweating in atopic dermatitis.

Wruhs M, Gleiß A, Steiner A, Sator P.

Arch Dermatol Res. 2017 Dec;309(10):787-793. doi: 10.1007/s00403-017-1770-z. Epub 2017 Sep 21.

PMID:
28936748
5.

[Intradermal metal deposits in an industrial worker].

Breier F, Loader D, Wasilewicz G, Brenner W, Sator P, Feldmann R, Stella A, Osterode W, Falkenberg G, Steiner A, Jurecka W.

Hautarzt. 2016 Jan;67(1):64-8. doi: 10.1007/s00105-015-3695-9. German.

PMID:
26452355
6.

Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.

Sator P, Richter L, Saxinger W, Vasiljevic M, Stingl G.

J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1742-9. doi: 10.1111/jdv.12981. Epub 2015 Feb 9.

PMID:
25665143
7.

Heparin-induced skin necrosis.

Sator P, Kiprov A, Feldmann R, Breier F, Steiner A.

J Eur Acad Dermatol Venereol. 2016 Jan;30(1):161-3. doi: 10.1111/jdv.12655. Epub 2014 Jul 30. No abstract available.

PMID:
25074633
8.

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.

Radakovic S, Breier-Maly J, Konschitzky R, Kittler H, Sator P, Hoenigsmann H, Tanew A.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):951-3. doi: 10.1111/j.1468-3083.2009.03138.x. Epub 2009 Jun 2.

PMID:
19496898
9.

Severe anaphylactic reaction to glatiramer acetate with specific IgE.

Rauschka H, Farina C, Sator P, Gudek S, Breier F, Schmidbauer M.

Neurology. 2005 Apr 26;64(8):1481-2. No abstract available.

PMID:
15851756
10.

Clinical profile of a new hormone replacement therapy containing 2 mg 17 beta-estradiol and 10 mg dydrogesterone.

Sator MO, Nagele F, Sator P, Travica S, Gruber D, Huber JC.

Maturitas. 2000 Mar 31;34(3):267-73.

PMID:
10717493

Supplemental Content

Loading ...
Support Center